Market Overview:
The global cerebral spinal fluid (CSF) management market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of hydrocephalus and other brain associated disorders, and the rising demand for minimally invasive procedures. Based on type, the CSF shunts segment is expected to account for the largest share of the global CSF management market in 2018. This segment is projected to grow at a CAGR of 6% from 2018 to 2030. The growth in this segment can be attributed to factors such as technological advancements and rising demand for minimally invasive procedures. Based on application, hydrocephalus treatment is expected to account for the largest share of the global CSF management market in 2018.
Product Definition:
Cerebral spinal fluid (CSF) management is the process of managing and monitoring cerebral spinal fluid. Cerebral spinal fluid is a clear, colorless liquid that surrounds and cushions the brain and spine. It helps to protect the brain from injury and helps to circulate nutrients and oxygen to the brain. The importance of cerebral spinal fluid management is that it helps to maintain proper function of the brain and spine, protects against injury, and circulates important nutrients to the brain.
CSF Shunts:
A Central Superior Neuropathic (CSN) shunt is a surgical procedure used to treat chronic pain caused by nerve damage in the spinal cord. A typical CNS shunt consists of two tubes, one of which is placed in the central nervous system (CNS), while the other is placed near but outside of the affected area. The tube that goes into the CNS carries away waste products from damaged areas and allows normal body functions to take place.
CSF Drainage:
A cerebral spinal fluid (CSF) drainage is a medical device used to drain the CSF from the brain or other body parts. It is mainly used for treating hydrocephalus and various other central nervous system disorders. The market for cerebral spinal fluid drainage and its usage in its management are growing at a significant rate owing to an increase in awareness about these devices, technological advancements, increasing prevalence of diseases such as hydrocephalus among others.
Application Insights:
Based on application, the global market has been segmented into hydrocephalus treatment, other brain associated disorders treatment and others. The other category includes conditions such as meningitis, arachnoiditis and spinal stenosis. Hydrocephalus is expected to be the largest segment over the forecast period owing to an increase in CSF related complications that require a surgical intervention for their management. Moreover, an increase in awareness about early diagnosis of this condition is anticipated to boost growth during the study period.
The other category includes conditions such as meningitis, arachnoiditis.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing incidence of hydrocephalus, rising awareness about available treatment options, and presence of well-established healthcare facilities in this region. Moreover, high adoption rate of advanced technologies for diagnosis and treatment is also expected to drive the demand for cadaveric cerebrospinal fluid (CSF) management during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing prevalence of neurological disorders due to increase in aging population or genetic predisposition coupled with environmental triggers such as exposure to toxic chemicals or viruses.
Growth Factors:
- Increasing incidence of neurological disorders: The global cerebral spinal fluid (CSF) management market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of neurological disorders such as meningitis, encephalitis, and hydrocephalus.
- Growing demand for minimally invasive surgeries: The growth of the CSF management market is also attributed to the growing demand for minimally invasive surgeries which offer several benefits over traditional open surgery procedures such as shorter hospital stay, reduced post-operative pain and complications, and faster recovery time.
- Rising awareness about CSF management procedures: There is a growing awareness among people about cerebrospinal fluid (CSF) management procedures which is driving the growth of this market. This can be attributed to initiatives taken by various government and non-government organizations to spread awareness about these procedures across different geographies.
- Technological advancements in CSF drainage devices: The technological advancements in CSF drainage devices are helping surgeons perform complex surgical procedures with ease thereby reducing post-operative complications associated with these surgeries.. This is further propelling the growth of this market segment during the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Cerebral Spinal Fluid (CSF) Management Market Research Report
By Type
CSF Shunts, CSF Drainage
By Application
Hydrocephalus Treatment, Other Brain Associated Disorders Treatment
By Companies
Magstim, B. Braun Melsungen, Johnson & Johnson, Integra Lifesciences, Spiegelberg, Medtronic, Sophysa, Beckersmith Medical, Elekta, Phoenix Biomedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Cerebral Spinal Fluid (CSF) Management Market Report Segments:
The global Cerebral Spinal Fluid (CSF) Management market is segmented on the basis of:
Types
CSF Shunts, CSF Drainage
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hydrocephalus Treatment, Other Brain Associated Disorders Treatment
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Magstim
- B. Braun Melsungen
- Johnson & Johnson
- Integra Lifesciences
- Spiegelberg
- Medtronic
- Sophysa
- Beckersmith Medical
- Elekta
- Phoenix Biomedical
Highlights of The Cerebral Spinal Fluid (CSF) Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CSF Shunts
- CSF Drainage
- By Application:
- Hydrocephalus Treatment
- Other Brain Associated Disorders Treatment
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cerebral Spinal Fluid (CSF) Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cerebral spinal fluid (CSF) management is the process of managing CSF in patients with brain or spine injuries. This includes ensuring that the CSF stays within a normal range, preventing infection, and providing treatment if needed.
Some of the key players operating in the cerebral spinal fluid (csf) management market are Magstim, B. Braun Melsungen, Johnson & Johnson, Integra Lifesciences, Spiegelberg, Medtronic, Sophysa, Beckersmith Medical, Elekta, Phoenix Biomedical.
The cerebral spinal fluid (csf) management market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cerebral Spinal Fluid (CSF) Management Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cerebral Spinal Fluid (CSF) Management Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cerebral Spinal Fluid (CSF) Management Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cerebral Spinal Fluid (CSF) Management Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cerebral Spinal Fluid (CSF) Management Market Size & Forecast, 2020-2028 4.5.1 Cerebral Spinal Fluid (CSF) Management Market Size and Y-o-Y Growth 4.5.2 Cerebral Spinal Fluid (CSF) Management Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 CSF Shunts
5.2.2 CSF Drainage
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hydrocephalus Treatment
6.2.2 Other Brain Associated Disorders Treatment
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cerebral Spinal Fluid (CSF) Management Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cerebral Spinal Fluid (CSF) Management Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 CSF Shunts
9.6.2 CSF Drainage
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hydrocephalus Treatment
9.10.2 Other Brain Associated Disorders Treatment
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 CSF Shunts
10.6.2 CSF Drainage
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hydrocephalus Treatment
10.10.2 Other Brain Associated Disorders Treatment
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 CSF Shunts
11.6.2 CSF Drainage
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hydrocephalus Treatment
11.10.2 Other Brain Associated Disorders Treatment
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 CSF Shunts
12.6.2 CSF Drainage
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hydrocephalus Treatment
12.10.2 Other Brain Associated Disorders Treatment
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 CSF Shunts
13.6.2 CSF Drainage
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hydrocephalus Treatment
13.10.2 Other Brain Associated Disorders Treatment
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cerebral Spinal Fluid (CSF) Management Market: Competitive Dashboard
14.2 Global Cerebral Spinal Fluid (CSF) Management Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Magstim
14.3.2 B. Braun Melsungen
14.3.3 Johnson & Johnson
14.3.4 Integra Lifesciences
14.3.5 Spiegelberg
14.3.6 Medtronic
14.3.7 Sophysa
14.3.8 Beckersmith Medical
14.3.9 Elekta
14.3.10 Phoenix Biomedical